{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-029856","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2022-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.893577+00:00","generated_at":"2026-06-22T23:05:51.574294+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Enveric Biosciences reports 2022 annual meeting results; all proposals pass","bullets":["Annual meeting quorum: 856,447 shares (41.2% of outstanding); all seven director nominees elected, with Joseph Tucker receiving 228,825 votes for.","Advisory vote on named executive officer compensation passed with 178,176 for, 68,125 against, 1,771 abstain.","Ratification of Marcum LLP as independent auditor approved with 826,728 for, 27,656 against, 2,063 abstain.","Broker non-votes totaled 608,375 on director election and advisory proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-029856","json":"https://secwatch.observer/filing/0001493152-22-029856.json","markdown":"https://secwatch.observer/filing/0001493152-22-029856.md","text":"https://secwatch.observer/filing/0001493152-22-029856.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/0001493152-22-029856-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T23:05:51.574294+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31f49ceed96acdea5a934cdef898e2a69fe8f75f","claim":"Enveric Biosciences, Inc. shareholders approved Election of seven directors at the 2022-10-28 meeting.","evidence_excerpt":"Nominee For Withheld Broker Non-Votes George Kegler 138,269 109,803 608,375","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/0001493152-22-029856-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-10-28"}],"fact_type":"shareholder_vote"},{"claim_id":"a25390206d9881002308f5d80400484f9b796f3a","claim":"Enveric Biosciences, Inc. shareholders approved Non-binding advisory vote to approve the compensation of the Company’s named executive officers at the 2022-10-28 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 178,176 68,125 1,771 608,375","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/0001493152-22-029856-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-10-28"}],"fact_type":"shareholder_vote"},{"claim_id":"f051b1c261897e432176def340aec36654c4af0e","claim":"Enveric Biosciences, Inc. shareholders approved Ratification of the selection and appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-10-28 meeting.","evidence_excerpt":"For Against Abstain 826,728 27,656 2,063","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/0001493152-22-029856-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-10-28"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}